Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.jocn.2021.05.019 http://scihub22266oqcxt.onion/10.1016/j.jocn.2021.05.019 34119280!8096173!34119280     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Clin+Neurosci 2021 ; 89 (ä): 271-278 Nephropedia Template TP {{tp|p=34119280|t=2021. Intracerebral hemorrhage in COVID-19: A narrative review |pdf=|usr=}}{{34119280}} gab.com Text Intracerebral hemorrhage in COVID-19: A narrative review JO: J Clin Neurosci http://www.kidney.de/pget.php?&tw=1&pmid=34119280 #FOAvip Coronavirus Disease 19 (COVID-19) pandemic affects the worldwide healthcare system and our understanding of this disease grows rapidly. Although COVID-19 is a mainly respiratory disease, neurological manifestations are not uncommon. The aim of this review is to report on the etiology, clinical profile, location, and outcome of patients with intracerebral hemorrhage (ICH) and COVID-19. This review includes 36 studies examining ICH in the clinical presentation of COVID-19. Overall, 217 cases with intracranial hemorrhage, of which 188 ICHs, were reported. Generally, a low incidence of both primary and secondary ICH was found in 8 studies [106 (0.25%) out of 43,137 hospitalized patients with COVID-19]. Available data showed a median age of 58 years (range: 52-68) and male sex 64%, regarding 36 and 102 patients respectively. Furthermore, 75% of the patients were on prior anticoagulation treatment, 52% had a history of arterial hypertension, and 61% were admitted in intensive care unit. Location of ICH in deep structures/basal ganglia was ascertained in only 7 cases making arterial hypertension an improbable etiopathogenetic mechanism. Mortality was calculated at 52.7%. Disease related pathophysiologic mechanisms support the hypothesis that SARS-CoV2 can cause ICH, however typical ICH risk factors such as anticoagulation treatment, or admission to ICU should also be considered as probable causes. Physicians should strongly suspect the possibility of ICH in individuals with severe COVID-19 admitted to ICU and treated with anticoagulants. It is not clear whether ICH is related directly to COVID-19 or reflects expected comorbidity and/or complications observed in severely ill patients. Twit Text FOAVip Intracerebral hemorrhage in COVID-19: A narrative review ????J Clin Neurosci http://www.kidney.de/pget.php?&tw=1&pmid=34119280 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34119280 #FOAvip English Wikipedia <ref>{{Cite pmid|34119280}}</ref> Intracerebral hemorrhage in COVID-19: A narrative review #MMPMID34119280 Margos NP; Meintanopoulos AS; Filioglou D; Ellul J J Clin Neurosci 2021[Jul]; 89 (ä): 271-278 PMID34119280show ga Coronavirus Disease 19 (COVID-19) pandemic affects the worldwide healthcare system and our understanding of this disease grows rapidly. Although COVID-19 is a mainly respiratory disease, neurological manifestations are not uncommon. The aim of this review is to report on the etiology, clinical profile, location, and outcome of patients with intracerebral hemorrhage (ICH) and COVID-19. This review includes 36 studies examining ICH in the clinical presentation of COVID-19. Overall, 217 cases with intracranial hemorrhage, of which 188 ICHs, were reported. Generally, a low incidence of both primary and secondary ICH was found in 8 studies [106 (0.25%) out of 43,137 hospitalized patients with COVID-19]. Available data showed a median age of 58 years (range: 52-68) and male sex 64%, regarding 36 and 102 patients respectively. Furthermore, 75% of the patients were on prior anticoagulation treatment, 52% had a history of arterial hypertension, and 61% were admitted in intensive care unit. Location of ICH in deep structures/basal ganglia was ascertained in only 7 cases making arterial hypertension an improbable etiopathogenetic mechanism. Mortality was calculated at 52.7%. Disease related pathophysiologic mechanisms support the hypothesis that SARS-CoV2 can cause ICH, however typical ICH risk factors such as anticoagulation treatment, or admission to ICU should also be considered as probable causes. Physicians should strongly suspect the possibility of ICH in individuals with severe COVID-19 admitted to ICU and treated with anticoagulants. It is not clear whether ICH is related directly to COVID-19 or reflects expected comorbidity and/or complications observed in severely ill patients. |Adult[MESH] |Aged[MESH] |Anticoagulants/pharmacology/therapeutic use[MESH] |Blood Coagulation/drug effects/physiology[MESH] |COVID-19 Drug Treatment[MESH] |COVID-19/*diagnostic imaging/*epidemiology[MESH] |Cerebral Hemorrhage/*diagnostic imaging/drug therapy/*epidemiology[MESH] |Hospitalization/trends[MESH] |Humans[MESH] |Hypertension/diagnostic imaging/drug therapy/epidemiology[MESH] |Intensive Care Units/trends[MESH] |Male[MESH] |Middle Aged[MESH] |Pandemics[MESH] |Risk Factors[MESH]Intracerebral hemorrhage in COVID-19: A narrative review (epmc).pdf DeepDyve Pubget Overpricing